Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7482429 | 0.72 | CYP2C9 (0.44) | MAPTCA1CA9HPGDLMNA | |
| SCHEMBL346071 | 0.72 | CA1 (0.41) | MAPTCA1CA9HPGDLMNA | |
| SCHEMBL14627844 | 0.71 | KDM4E (0.52) | MAPTCA1CA9GABRA1FAAH | |
| SCHEMBL13150866 | 0.71 | KDM4E (0.38) | MAPTCA1CA9GABRA1FAAH | |
| SCHEMBL17530314 | 0.70 | — | — | |
| SCHEMBL11877385 | 0.70 | KMT2A (0.41) | MAPTCA1CA9HPGDLMNA | |
| SCHEMBL14602504 | 0.70 | MAPT (0.42) | MAPTCA1CA9GABRA1FAAH | |
| SCHEMBL980904 | 0.69 | — | — | |
| SCHEMBL30458138 | 0.68 | GABRA1 (0.45) | MAPTCA1CA9GABRA1GABRB2 | |
| SCHEMBL80874 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109722405-B | Recombinant escherichia coli for producing isopropyl pyrone by utilizing glucose and application | 创享(天津)生物科技发展有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-109722405-B | Recombinant escherichia coli for producing isopropyl pyrone by utilizing glucose and application | 创享(天津)生物科技发展有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-109722405-B | Recombinant escherichia coli for producing isopropyl pyrone by utilizing glucose and application | 创享(天津)生物科技发展有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-109722405-B | Recombinant escherichia coli for producing isopropyl pyrone by utilizing glucose and application | 创享(天津)生物科技发展有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-7989430-B2 | Antibacterial agents | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2011-08-02 | — | — | US | disclosed |
| US-7989430-B2 | Antibacterial agents | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2011-08-02 | — | — | US | disclosed |
| CN-100532556-C | Coded vitamin B6Gene of phosphate phosphatase and use thereof | DSM IP ASSETS BV (NL) | 2009-08-26 | — | — | CN | disclosed |
| US-20080293666-A1 | Antibacterial Agents | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2008-11-27 | — | — | US | disclosed |
| CN-1685044-A | A gene encoding vitamin B 6 phosphate phosphatase and use thereof | DSM IP ASSETS BV (NL) | 2005-10-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293666-A1 | Antibacterial Agents | MRPL21, ABCB7, MSR1 | MAPT 4800/4885CA1 4489/4885CA9 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.